Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

NCT00755118 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Due to poor Accrual

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Cetuximab

Sponsor

University Hospital of Crete